Screener
United Therapeutics UTHR Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: United Therapeutics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001082554-26-000020
FAQ
- What is United Therapeutics's gross margin?
- United Therapeutics (UTHR) reported gross margin of 86.6% in Q1 2026.
- How has United Therapeutics's gross margin changed year-over-year?
- United Therapeutics's gross margin decreased by 2.7% year-over-year, from 89% to 86.6%.
- What is the long-term trend for United Therapeutics's gross margin?
- Over 5 years (2020 to 2025), United Therapeutics's gross margin has grown at a -1.1% compound annual growth rate (CAGR), from 92.7% to 87.9%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about United Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude